The Use of Preliminary Scientific Evidence in Public Health: A Case Study of XMRV

PLoS Medicine

Volumn 11, Issue 4, 2014, Pages

  Wilson, Kumanan ^a,b   Atkinson, Katherine ^b   Keelan, Jennifer ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; BLOOD DONOR; CHRONIC FATIGUE SYNDROME; COMMUNICABLE DISEASE; DECISION MAKING; HEALTH CARE POLICY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MENTAL DISEASE; PROSTATECTOMY; PUBLIC HEALTH; PUBLICATION; SCIENTIFIC LITERATURE; SOCIAL MEDIA; THREAT; VIRUS TRANSMISSION; XENOTROPIC MULV RELATED VIRUS; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; PHYSIOLOGY; PUBLISHING; RETROVIRIDAE INFECTIONS; TRANSMISSION; VIROLOGY;

BLOOD DONORS; EDITORIAL POLICIES; HEALTH POLICY; HUMANS; POLICY MAKING; PUBLIC HEALTH; RETROVIRIDAE INFECTIONS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84900452986     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001623     Document Type: Article

References (30)

1. Kakisi OK, Robinson MJ, Tettmar KI, Tedder RS, (2013) The rise and fall of XMRV. Transfus Med 23: 142-151.
2. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 5: e8519.
3. van Kuppeveld FJ, van der Meer JW, (2012) XMRV and CFS-the sad end of a story. Lancet 379: e27-28.
4. Karafin MS, Stramer SL, (2012) The scientific method at work: xenotropic murine leukemia virus-related virus is neither a cause of chronic fatigue syndrome nor a threat to the blood supply. Transfusion 52: 222-225.
5. Dodd RY, (2011) Chronic fatigue syndrome, XMRV and blood safety. Future Microbiol 6: 385-389.
6. Dodd RY, Hackett J Jr, Linnen JM, Dorsey K, Wu Y, et al. (2012) Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety. Transfusion 52: 298-306.
7. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
8. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
9. Alberts B, (2011) Retraction. Science 334: 1636.
10. Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, et al. (2011) Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 334: 176.
11. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, et al. (2012) Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 109: 346.
12. Wilson K, (2011) A framework for applying the precautionary principal to transfusion safety. Transfus Med Rev 25: 177-183.
13. Dodd RY, (2011) XMRV and blood safety: a case study of science and public pressure. ISBT Sci Ser 6: 446-448.
14. Martuzzi M (2004) The precautionary principle protecting public health, the environment and the future of our children. World Health Organization, Regional Office for Europe.
15. Commission of the European Communities (2000) Communication from the commission on the precautionary principle. COM(2000) 1 (Brussels: 2 February 2000). Available: http://ec.europa.eu/dgs/health_consumer/library/pub/pub07_en.pdf. Accessed 2 March 2014.
16. Wilson K, Ricketts MN, (2004) The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease. Transfusion 44: 1475-1478.
17. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, et al. (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351: 637-641.
18. Increased transmission and outbreaks of measles, European Region, 2011. Wkly Epidemiol Rec 86: 559-564.
19. Baker JP, (2008) Mercury, vaccines, and autism: one controversy, three histories. Am J Public Health 98: 244-253.
20. Stratton K, Gable A, Shetty P, McCormick M, (2001) Immunization safety review. Committee, Board on Health Promotion and Disease Prevention pp. 2.
21. Weir E, Schabas R, Wilson K, Mackie C, (2010) A Canadian framework for applying the precautionary principle to public health issues. Can J Public Health 101: 396-398.
22. Wainberg MA, Shuldiner T, Dahl K, Gilmore N, (2010) Reconsidering the lifetime deferral of blood donation by men who have sex with men. CMAJ 182: 1321-1324.
23. Wilson K, Atkinson K, Keelan J, (2014) Three decades of MSM donor deferral policies. What have we learned? Int J Infect Dis 18: 1-3.
24. Slovic P, (1987) Perception of risk. Science 236: 280-285.
25. Australian Red Cross Blood Service (2010) Blood Service updates CFS donor policy. Available: http://www.donateblood.com.au/media-centre/latest-national-news/blood-service-updates-cfs-donor-policy. Accessed 25 March 2013.
26. Canadian Blood Services (2010) Indefinite deferral for history of chronic fatigue syndrome. Available: http://www.blood.ca/centreapps/internet/uw_v502_mainengine.nsf/page/Indefinite_Deferral_for_History_of_Chronic_Fatigue_Syndrome?OpenDocument. Accessed 14 March 2013.
27. NHSBT (2010) ME/CFS sufferers permanently deferred from giving blood.
28. AABB (2010) Recomendations on chronic fatigue syndrome and blood donation.
29. European Centre for Disease Prevention and Control (2011) Risk assesssment on xenotropic murine leukemia virus-related virus (XMRV) and its implications for blood donation. Stockholm.
30. New Zealand Blood Service (2010) XMRV - A new transfusion transmitted infection? Blood Issues, Issue 24.